Literature DB >> 11266766

MHC class II compatibility between donor bone marrow and secondary organ grafts is required for tolerance based on mixed chimerism.

M D Jäger1, T Tsui, K Timrott, H Aselmann, A Deiwick, M Neipp, K Wonigeit, J Klempnauer, H J Schlitt.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11266766     DOI： 10.1016/s0041-1345(00)01962-x

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  2 in total

1.  Application of allogeneic bone marrow cells in view of residual alloreactivity: sirolimus but not cyclosporine evolves tolerogenic properties.

Authors:  Kai Timrott; Florian W R Vondran; Hueseyin Bektas; Jürgen Klempnauer; Mark D Jäger
Journal:  PLoS One       Date:  2015-04-02       Impact factor: 3.240

2.  The importance of MHC class II in allogeneic bone marrow transplantation and chimerism-based solid organ tolerance in a rat model.

Authors:  Kai Timrott; Oliver Beetz; Felix Oldhafer; Jürgen Klempnauer; Florian W R Vondran; Mark D Jäger
Journal:  PLoS One       Date:  2020-05-22       Impact factor: 3.240
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.